In The Lancet Neurology, Scott E Kasner and colleagues report the results of a subgroup analysis of the NAVIGATE ESUS trial comparing rivaroxaban ... read more
Optimal stroke prevention in patients with patent foramen ovale
Optimal stroke prevention in patients with patent foramen ovale
